Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma.

Piquemal D, Bruno R, Bournet B, Ghiringhelli F, Noguier F, Canivet C, Bertaut A, Pierrat F, Evesque L, Gamez A, Cros J, Rederstorff E, Petit E, Adnet J, Saint A, Drouillard A, Kempf E, Soularue E, Vincent J, Baumgaertner I, Hennequin A, Tournigand C, Lopez Trabada Ataz D, Bengrine L, Lepage C, Manfredi S, Afchain P, Trouilloud I, Gagnaire A, LoConte NK, Bachet JB

Open source

DOI: 10.21037/jgo-22-946
Published: 2023 Apr 29
Container: Journal of gastrointestinal oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.21037/jgo-22-946,
  title = {Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma.},
  author = {Piquemal D and Bruno R and Bournet B and Ghiringhelli F and Noguier F and Canivet C and Bertaut A and Pierrat F and Evesque L and Gamez A and Cros J and Rederstorff E and Petit E and Adnet J and Saint A and Drouillard A and Kempf E and Soularue E and Vincent J and Baumgaertner I and Hennequin A and Tournigand C and Lopez Trabada Ataz D and Bengrine L and Lepage C and Manfredi S and Afchain P and Trouilloud I and Gagnaire A and LoConte NK and Bachet JB},
  year = {2023},
  journal = {Journal of gastrointestinal oncology},
  doi = {10.21037/jgo-22-946},
  url = {https://doi.org/10.21037/jgo-22-946}
}

RIS

TY  - JOUR
TI  - Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma.
AU  - Piquemal D
AU  - Bruno R
AU  - Bournet B
AU  - Ghiringhelli F
AU  - Noguier F
AU  - Canivet C
AU  - Bertaut A
AU  - Pierrat F
AU  - Evesque L
AU  - Gamez A
AU  - Cros J
AU  - Rederstorff E
AU  - Petit E
AU  - Adnet J
AU  - Saint A
AU  - Drouillard A
AU  - Kempf E
AU  - Soularue E
AU  - Vincent J
AU  - Baumgaertner I
AU  - Hennequin A
AU  - Tournigand C
AU  - Lopez Trabada Ataz D
AU  - Bengrine L
AU  - Lepage C
AU  - Manfredi S
AU  - Afchain P
AU  - Trouilloud I
AU  - Gagnaire A
AU  - LoConte NK
AU  - Bachet JB
PY  - 2023
JO  - Journal of gastrointestinal oncology
DO  - 10.21037/jgo-22-946
UR  - https://doi.org/10.21037/jgo-22-946
ER  -

APA

D, P., R, B., B, B., F, G., F, N., C, C., A, B., F, P., L, E., A, G., J, C., E, R., E, P., J, A., A, S., A, D., E, K., E, S., J, V., I, B., A, H., C, T., D, L. T. A., L, B., C, L., S, M., P, A., I, T., A, G., NK, L., & JB, B. (2023). Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma.. Journal of gastrointestinal oncology. https://doi.org/10.21037/jgo-22-946

Source records

pubmed · retrieved 2026-09-26T11:27:49.232Z